# Cerecin clinical trials: 22 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with Cerecin as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Cerecin: 22 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/cerecin

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| April 12, 2023 | NCT05809908 | Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study | Cerecin | Phase 3 | Not yet recruiting | Alzheimer Disease | 535 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05809908) |
| November 29, 2022 | NCT05628636 | AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions | Cerecin | Phase 1 | Completed | Alzheimer Disease | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05628636) |
| June 7, 2022 | NCT05408780 | A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and... | Cerecin | Phase 1 | Completed | Alzheimer Disease | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05408780) |
| August 31, 2021 | NCT05028114 | Tricaprilin Liquid Formulation PK Study | Cerecin | Phase 1 | Terminated | Alzheimer Disease | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05028114) |
| January 27, 2021 | NCT04727970 | Tricaprilin Infantile Spasms Pilot Study | Cerecin | Phase 1 | Completed | Infantile Spasm | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04727970) |
| June 18, 2020 | NCT04437199 | Tricaprilin Phase 2 Pilot Study in Migraine | Cerecin | Phase 2 | Completed | Migraine | 83 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04437199) |
| February 13, 2020 | NCT04268953 | Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production | Cerecin | Phase 1 | Completed | Alzheimer Disease | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04268953) |
| December 5, 2019 | NCT04187547 | A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional... | Cerecin | Phase 3 | Withdrawn | Alzheimer's Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04187547) |
| June 3, 2019 | NCT03971123 | Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production | Cerecin | Phase 1 | Completed | Alzheimer Disease | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03971123) |
| August 17, 2018 | NCT03635879 | Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides | Cerecin | Phase 1 | Withdrawn | Alzheimer Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03635879) |
| August 14, 2018 | NCT03628352 | Taste-masking Study for Tricaprilin in Sensory Panelists | Cerecin | Phase 1 | Completed | Taste Profile Assessments | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03628352) |
| June 11, 2018 | NCT03551769 | Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production | Cerecin | Phase 1 | Completed | Alzheimer Disease | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03551769) |
| February 24, 2017 | NCT03063645 | Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production | Cerecin | Phase 1 | Completed | Healthy | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03063645) |
| November 9, 2016 | NCT02959710 | Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production | Cerecin | Phase 1 | Completed | Healthy | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02959710) |
| July 14, 2016 | NCT02833012 | Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production | Cerecin | Phase 1 | Completed | Healthy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02833012) |
| April 22, 2016 | NCT02747602 | Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production | Cerecin | Phase 1 | Completed | Healthy | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02747602) |
| December 4, 2012 | NCT01741194 | AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext | Cerecin | Phase 2/3 | Completed | Alzheimer's Disease | 418 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01741194) |
| February 24, 2012 | NCT01538212 | Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease | Cerecin | Observational | Completed | Alzheimer's Disease | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01538212) |
| September 30, 2010 | NCT01211782 | AC-1204 Long-term Efficacy Response Trial (ALERT Protocol) | Cerecin | Phase 2/3 | Withdrawn | Alzheimer's Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01211782) |
| April 17, 2008 | NCT00660088 | Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly | Cerecin | Observational | Completed | Alzheimer's Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00660088) |
| July 24, 2006 | NCT00355550 | Tricaprilin In Age-Associated Memory Impairment | Cerecin | Phase 2 | Completed | Age-Associated Memory Impairment | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00355550) |
| September 2, 2005 | NCT00142805 | Tricaprilin in Mild to Moderate Alzheimer's Disease | Cerecin | Phase 2 | Completed | Alzheimer's Disease | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00142805) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 13 |
| Phase 2 | 3 |
| Phase 2/3 | 2 |
| Phase 3 | 2 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 17 |
| Withdrawn | 3 |
| Terminated | 1 |
| Not yet recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Alzheimer Disease | 14 |
| Ketosis | 2 |
| Migraine Disorders | 1 |
| Spasms, Infantile | 1 |
| Cognitive Dysfunction | 1 |
| Cognition Disorders | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Specialty hospitals in the United States](https://specstream.ai/data/businesses/specialty-hospitals/united-states)
- [Public utilities in the United States](https://specstream.ai/data/businesses/public-utilities/united-states)
- [Pathology practices in the United States](https://specstream.ai/data/businesses/pathology-practices/united-states)
- [Medical law firms in the United States](https://specstream.ai/data/businesses/medical-law-firms/united-states)
- [International fusion restaurants in the United States](https://specstream.ai/data/businesses/international-fusion-restaurants/united-states)
- [Glass companies in the United States](https://specstream.ai/data/businesses/glass-companies/united-states)
